Satellite TV

Viking Therapeutics to Present New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The International Liver Congress™ 2019

Chief Editor April 4, 2019 0 11 sec read
SAN DIEGO April 4, 2019 /PRNewswire/ — Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX ), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that data from the company’s 12-week Phase 2 study of VK2809 in….


Read all

Chief Editor

View More Posts

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Convoy of protesters travels through Waikiki, urging visitors to leave amid coronavirus fears

A three-hour convoy of roughly 75 to 100 honking vehicles, many flying Hawaiian flags, traveled from the Daniel K. Inouye International Airport to Waikiki today […]

March 21, 2020 0 13 sec read

PJIA aims to move operations back into terminal building by November

Preparing for increase of flights. AIRPORT–The Princess Juliana International Airport (PJIA) managing board plans to move the airport’s departure and arrival operations temporarily into the […]

July 17, 2018 0 11 sec read

Azerbaijan IBA creditors offered swap into sovereign debt

The International Bank of Azerbaijan has offered creditors several options in its debt restructuring, including swapping into 12- or 15-year sovereign bonds, the former involving […]

May 23, 2017 0 12 sec read

Southwest plane makes emergency landing at Philly airport

PHILADELPHIA (WTXF) – PHILADELPHIA (AP/WTXF) — A Southwest Airlines plane has made an emergency landing at Philadelphia International Airport with what appears to be a […]

April 17, 2018 0 11 sec read